艾媒报告|2016Q1中国上门美业O2O行业研究报告

艾媒数据显示，2016Q1，在中国上门美业O2O用户对上门美业O2O应用知名度调查中，58到家(包含嘟嘟美甲)、河狸家、俏猫分列前三位，占比依次为49.2%、33.5%和30.1%。艾媒分析师认为，58到家和河狸家凭借对市场的先入优势，已积累一定的知名度。

艾媒咨询|2022中国化妆品行业新业态大数据趋势报告

1月13日下午，由中国国际贸易促进委员会汕头市委员会、汕头市化妆品行业协会主办，汕头国际商会、汕头市万邦化妆品有限公司承办，国家洗涤护肤用品质量检验检测中心（广东）协办的“中国化妆品产业发展·汕头峰会”在广东汕头召开。
在本次活动现场，艾媒咨询CEO兼首席分析师张毅重磅发布了《2022中国化妆品行业新业态大数据趋势报告》，透过大数据看中外化妆品市场。报告围绕化妆品行业市场规模、进出口金额数量、投融资事件与融资金额、消费者行为监测等方面进行分享，为化妆品行业发展带来新观点、新视角和新机遇。

艾媒咨询|2021年10-11月中国本地生活行业投融资数据分析简报

伴随消费升级，消费者需求逐渐多样化，本地生活服务面进一步扩大。如今，本地生活行业已逐步迈进万亿市场。近年来，在数字经济的加持下，本地生活行业进行了数字化升级，并发展成为最活跃的行业之一，得到了资本市场的大量关注。艾媒咨询通过艾媒数据中心(data.iimedia.cn)查询并发布《2021年10-11月中国本地生活行业投融资数据分析简报》，助力投资人与创业者用户即时了解市场趋势，获取关键投资决策所需的数据，把握投资逻辑和最新产业机会。
With the upgrading of consumption, consumer demand is gradually diversified, and the local life service area is further expanded. Today, the local living industry has gradually entered a trillion market. In recent years, with the support of the digital economy, the local living industry has been digitally upgraded and developed into one of the most active industries, which has attracted a lot of attention from the capital market.iiMedia Research inquires and publishes the analysis briefing on investment and financing data of local life industry in China from October to November 2021 through iimedia data center (data. iimedia.cn), which helps investors and entrepreneurs understand the market trend in real time, obtain the data required for key investment decisions, and grasp the investment logic and the latest industrial opportunities.

艾媒咨询|2021年中国美甲行业调研分析报告

2021年9月5日，由CIBE中国国际美博会主办的“美甲店全域增长高峰论坛”将在广州•广交会展馆举办。峰会将直击美甲门店发展的新风口、新流量、新营销、新爆品四大维度出发，共同探讨美甲店未来发展方向，如何利用抖音直播、小红书等新媒体平台，打通全域拓客营销？如何选对爆品品项，引爆门店生意持续增长！艾媒咨询CEO兼首席分析师张毅受邀出席本次峰会并将现场发布《2021年中国美甲行业调研分析报告》，将利用艾媒大数据决策和智能分析系统的数据挖掘结果，洞察消费者需求和中国美甲市场现状，并预判行业未来发展趋势。
On September 5, 2021, the "global growth Summit Forum of nail salons" hosted by cibe China International Beauty Expo will be held in the exhibition hall of Guangzhou • Canton Fair. Tiktok will take manicure stores to develop new outlets, new traffic, new marketing and new explosive products. Four aspects of joint development will be explored together with the future direction of Manicure store. How can we use the new media platform such as live broadcast, red book and so on to open up the global marketing? How to choose the right explosive items to detonate the continuous growth of store business! Zhang Yi, CEO and chief analyst of AI media consulting, was invited to attend the summit and will release the research and analysis report on China's nail industry in 2021. He will use the data mining results of AI media's big data decision-making and intelligent analysis system to gain insight into consumer demand and the current situation of China's nail Market, and predict the future development trend of the industry.

艾媒咨询|2021年中国医美机构市场竞争态势及企业营销模式分析报告

本报告研究涉及企业/品牌/案例：华韩整形，瑞丽医美，美莱整形，医思健康

数据显示，2016—2020年中国医美行业市场规模五年平均增长率为12.8%，与此同时，中国医美市场用户规模增长了4倍多。在人们生活水平的提升、年轻一代对医美的接受度的提高、政府监管层对医美行业的整治给医美消费者信心的提升的综合作用下，预计中国医美市场规模在2022年将达到2232亿元。随着医美产品及仪器技术水平提升、医美知识普及等，民众对整形美容的观念正在向积极态度转变，在整个行业扩张的过程中，轻医美的受众面广、门槛低、复购率高，更有可能提升市场整体渗透率，成为我国医美行业的主要增量市场。
According to the data, from 2016 to 2020, the five-year average growth rate of the market scale of China's medical and American industry was 12.8%. At the same time, the user scale of China's medical and American market increased by more than four times. Under the combined effect of the improvement of people's living standards, the improvement of the acceptance of medical beauty by the younger generation, the regulation of the medical beauty industry by the government regulators and the improvement of medical beauty consumer confidence, it is expected that the scale of China's medical beauty market will reach 223.2 billion yuan in 2022. With the improvement of the technical level of medical beauty products and instruments and the popularization of medical beauty knowledge, people's concept of plastic beauty is changing to a positive attitude. In the process of the expansion of the whole industry, light medical beauty has a wide audience, low threshold and high repurchase rate, which is more likely to improve the overall penetration rate of the market and become the main incremental market of China's medical beauty industry.

艾媒报告 |2018-2019中国医疗美容行业研究与产业链分析报告

本报告研究涉及企业/品牌包括:新氧、更美、悦美、美黛拉、美丽神器、美呗、南方医院、伊美尔、熙朵、碧莲盛、雍禾植发、科发源植发、新生植发、恒博医疗、昊海生物科技、华熙生物、复星医药、深圳鹏爱医疗美容医院、北京丽都医疗美容医院

中国医疗美容行业处于快速发展期，iiMedia Research（艾媒咨询）监测发现，2018年中国医美行业市场规模达2245亿元，牙齿美容及面部美容是医美市场的重要构成部分，占比分别达32.5%和35.3%。目前中国医美行业已形成生产商、医美机构、终端市场三大产业链环节，产业发展前景广阔，但作为新兴行业，中国医疗美容行业将面临着行业监管、公共关系危机、行业竞争激烈等几大风险。

Driven by the rise of the younger generation of consumer groups and the development of new models in the medical beauty industry, the penetration rate and consumer demand of China's medical beauty industry continue to rise. In 2018, the penetration rate of Chinese medical users reached 7.4%, and women were the main medical and aesthetic consumers. The proportion is 88.9%. At present, there are more than 10,000 registered medical and beauty institutions in China, and the industry is in a period of rapid development. iiMedia Research found that embedding, double eyelids, and full body fat filling are the favorite surgical items for Chinese women and medical consumers, while nasal synthesis, tautological fat, cheeks, hair transplants, etc. For the Chinese male medical beauty consumer's favorite surgical project, potential customers in China's medical beauty industry are most concerned about the safety of surgery, followed by medical qualifications and word of mouth and surgery prices. Medical beauty as an emerging industry, public relations crisis, strict industry supervision, lack of relevant professionals is a factor that restricts its development, and in the future, with the influx of capital from the industry, the competition in China's medical and aesthetic industry will become more intense.

艾媒咨询|2021年中国轻医美行业研究及产业链分析报告

本报告研究涉及企业/品牌/案例：爱美客，华熙生物，奇致激光，华韩整形，新氧，兰州生物

数据显示，2020年中国轻医美用户市场规模达到1520万人，预计到2021年将增至1813万人。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展，预计2021年中国轻医美市场将达到798亿元，同比增长46.4%。在行业快速增长的同时，轻医美产业链各环节企业由于集中度不同导致利润分配不均，具体来看，上游原料耗材企业由于高技术壁垒，市场集中度较高，毛利率高于中下游企业，如知名玻尿酸、肉毒素产品制造企业爱美客、华熙生物等，而中下游由于竞争分散，单体获利参差不齐，更容易产生乱象。但总体来说，在行业监管加强、机构自律、平台监督等多方力量共同作用下，轻医美行业将会向线上化、品牌化、规范化发展。
According to the data, the market size of China's light medical beauty users will reach 15.2 million in 2020, and it is expected to increase to 18.13 million by 2021. Driven by the awakening of consumer awareness and consumer demand, institutions and doctors strongly boost the rapid development of light medical beauty industry in the supply side. It is estimated that China's light medical beauty market will reach 79.8 billion yuan in 2021, with a year-on-year growth of 46.4%. With the rapid growth of the industry, the profit distribution of enterprises in each link of the light medical beauty industry chain is uneven due to different concentration. Specifically, due to high technical barriers, the upstream raw materials and consumables enterprises have higher market concentration and higher gross profit rate than the middle and downstream enterprises, such as the well-known hyaluronic acid, botulinum toxin product manufacturing enterprises aimekke, Huaxi biology, etc., while the middle and downstream enterprises have higher gross profit rate due to scattered competition, Individual profit is uneven, more likely to produce chaos. But on the whole, under the joint action of industry supervision, institutional self-discipline, platform supervision and other forces, the light medical beauty industry will develop to online, brand and standardization.

艾媒研报 |2019H1新氧运行状况与商业趋势研究报告

本报告研究涉及企业/品牌/案例：腾讯，经纬中国，挚信资本，兰馨亚洲，安佰深中国，鼎晖投资，康辉医疗，瑞奇外科，星童医疗，美柚，V大夫，掌上糖医，药品终端网，GHG，Syneron Candela，郝海生物科技，华熙生物，复星医药，北京丽都医疗美容医院，深圳鹏爱医疗美容医院，更美，悦美，新氧，美黛拉，美呗，美丽神器

iiMedia Research(艾媒咨询)数据显示，2018年中国医美产业市场规模达2190亿元，预计2021年将突破3000亿元，行业增长快速，前景广阔。医美平台是医疗美容机构的获客新渠道，能够帮助医美机构实现精准营销，提升盈利空间。在行业加速发展的过程中，医美平台寡头格局逐步形成。新氧作为头部平台，已在用户数量、社区内容、医疗机构资源等方面有较多积累，在马太效应作用下，更易形成商业价值增长的良性循环。但随着规模扩张，平台上滋生了虚假日记、刷单等“灰色产业”，极大的损害了新氧的形象。然而机构和用户数量的增长不断增加新氧的审核难度，维护平台公信力的挑战升级。另外，随着互联网巨头以及老牌上市公司的入局，行业竞争加剧，新氧要面临来自用户规模、资金实力、技术实力、行业资源等多方面的围剿，未来发展道路阻碍重重。

According to iiMedia Research, in 2018, the scale of China's medical aesthetic market reached 219 billion yuan, and is expected to exceed 300 billion yuan in 2021. Chinese medical aesthetic industry is growing rapidly and considerably, bringing a broad prospect. The medical aesthetic platform is a new channel for medical aesthetic institutions, which can help medical institutions achieve accurate marketing and improve profitability. In the process of the accelerating development of the industry, a oligarchic pattern of the medical beauty platform has gradually formed. As a head platform, So-Young has accumulated a large scale of users, community content, medical institutions and other resources. Under the effect of Matthew effect, it is easier for So-Young to form a virtuous circle of commercial value growth. However, with the development, a ““gray industry““ consists of virtual holiday notes and brush sheets has emerged on the platform, which greatly damaged the image of So-Young. Meanwhile, the growth in the number of institutions and users increases the difficulty of platform audition, making the maintenance of its credibility even more challenging. In addition, with the Internet giants and established listed companies entering the game, the competition tends to be intensified. So-Young would have to face the pressure from user scale, financial strength, technical strength, and industry resources, which is rather challenging.

艾媒咨询 | 2025年中国医美行业发展状况与消费行为调查数据

随着消费升级与技术迭代，中国医美行业已从传统整形扩展至轻医美、抗衰老等多元化领域，市场规模持续扩大。根据全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国医美行业发展状况与消费行为调查数据》显示，2025年中国医美服务行业市场规模为3701亿元，2025年中国轻医美市场用户规模达3105万人。中国医美市场的增长不仅源于消费升级，也得益于技术普惠与轻医美项目的高复购率。当前行业已进入以精细化运营、差异化服务和合规化发展为核心驱动的新阶段。
在2025年中国消费者对医美项目的接受程度中，“会考虑整形，但风险要相对可控”位列第一，占比46.02%；其次是“能够接受手术医美整形，并承受一定风险”，占比22.94%。此外，在消费者接受过的医美项目中，轻医美（非手术类）占比最高，达到74.45%；医美整形（手术类）的占比为33.52%。这表明中国消费者对医美的态度趋于理性与谨慎，安全可控的非手术类项目成为市场主流偏好。同时，手术类项目亦拥有稳定的需求群体，显示出市场需求的层次性与多元化。
艾媒咨询分析师认为，未来中国医美市场将延续“轻医美主导、技术驱动、合规深化”的主线发展。一方面，非手术项目凭借低风险、高复购优势，仍是增长核心，Z世代与男性、下沉市场需求进一步释放。另一方面，再生材料、AI个性化方案及智能器械加速迭代，推动服务精准化与效果革新。此外，监管常态化下，行业加速品牌化整合，合规机构与上游技术型企业凸显优势。总的来说，消费者更趋理性，追求自然效果与安全保障，倒逼市场从营销竞争转向以品质、精细化运营为核心的高质量发展新阶段。
With the upgrading of consumption and technological advancements, China's medical aesthetics industry has expanded from traditional plastic surgery to diversified fields such as minimally invasive aesthetics and anti-aging. The market size has continued to grow. According to the latest "2025 China Medical Aesthetics Industry Development Status and Consumer Behavior Survey Data" released by iiMedia Research, a leading third-party data mining and analysis institution for the new economy industry, the market size of China's medical aesthetics service industry will reach 370.1 billion yuan in 2025, and the user scale of the minimally invasive aesthetics market in China will reach 31.05 million people in 2025. The growth of China's medical aesthetics market is not only due to the upgrading of consumption but also benefits from the popularization of technology and the high repurchase rate of minimally invasive aesthetics projects. Currently, the industry has entered a new stage driven by refined operation, differentiated services, and compliance development.
In terms of Chinese consumers' acceptance of medical aesthetics projects in 2025, "Would consider plastic surgery, but the risk should be relatively controllable" ranks first, accounting for 46.02%; followed by "Can accept surgical medical aesthetics and bear certain risks", accounting for 22.94%. Additionally, among the medical aesthetics projects consumers have received, minimally invasive aesthetics (non-surgical) accounts for the highest proportion, reaching 74.45%; surgical medical aesthetics accounts for 33.52%. This indicates that Chinese consumers' attitudes towards medical aesthetics are becoming more rational and cautious, and non-surgical projects with low risks and high repurchase rates have become the mainstream preference in the market. At the same time, surgical projects also have a stable demand group, demonstrating the hierarchical and diversified nature of market demand.
Analysts from iiMedia Research believe that in the future, China's medical aesthetics market will continue to develop along the main line of "minimally invasive aesthetics dominance, technology-driven, and compliance deepening". On the one hand, non-surgical projects, with their low-risk and high-repurchase advantages, will remain the core of growth, and the demands of Generation Z, men, and consumers in lower-tier cities will be further released. On the other hand, regenerative materials, AI personalized solutions, and intelligent devices will accelerate iteration, promoting the precision and effect innovation of services. Moreover, under the normalization of regulation, the industry will accelerate brand integration, and compliant institutions and upstream technology enterprises will highlight their advantages. In summary, consumers are becoming more rational, pursuing natural effects and safety guarantees, which will force the market to shift from marketing competition to high-quality development centered on quality and refined operation.

美好置业：2021年第三季度报告